Mesna Injection Manufacturer & Exporter in India | Uroprotective Chemotherapy Support

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Mesna Injection is a uroprotective medication used to prevent hemorrhagic cystitis and urinary tract toxicity associated with certain chemotherapy agents, particularly ifosfamide and cyclophosphamide. The medicine works by binding to toxic metabolites in the urinary tract and neutralizing their harmful effects. Genliva Wellness LLP is a trusted Mesna Injection Manufacturer in India offering high-quality oncology supportive care formulations for domestic and international pharmaceutical markets.

This injectable formulation is commonly administered alongside chemotherapy to protect the bladder and urinary system from treatment-related complications. As a reliable Mesna Injection Exporter from India, Genliva Wellness LLP supplies quality-assured supportive care products to healthcare institutions and pharmaceutical distributors worldwide.

Mesna plays a crucial role in oncology supportive care by helping minimize chemotherapy-induced urinary toxicity and improving the safety profile of cancer treatment regimens.

Mesna Injection is formulated to provide effective protection against chemotherapy-induced urinary tract toxicity.

Contains Mesna as the active ingredient
Uroprotective agent used in oncology care
Neutralizes toxic urinary metabolites
Helps protect the bladder lining
Reduces risk of hemorrhagic cystitis
Suitable for intravenous administration

Mesna Injection is used to prevent urinary tract complications associated with specific chemotherapy treatments.

Prevention of hemorrhagic cystitis
Protection during ifosfamide therapy
Protection during cyclophosphamide therapy
Reduction of chemotherapy-induced bladder toxicity
Oncology supportive care
Urinary tract protection during cancer treatment

Mesna Injection helps improve the safety and tolerability of chemotherapy regimens.

Protects the urinary bladder from toxic effects
Reduces the risk of chemotherapy-related complications
Supports safer administration of anticancer medicines
Helps maintain urinary tract health during treatment
Enhances patient tolerance to chemotherapy
Contributes to improved supportive cancer care